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ABSTRACT The termination of protein synthesis is en-
coded by in-frame nonsense (stop) codons. Most organisms use
three nonsense codons: UGA, UAG, and UAA. In contrast to
sense codons, which are decoded by specific tRNAs, nonsense
codons are decoded by proteins called release factors (RFs).
Here we report the cloning of a mammalian RF cDNA by the
use of monoclonal antibodies specific for rabbit RF. Functional
studies showed that, when expressed in Escherichia cofi, the
protein encoded by this cDNA has in vitro biochemical char-
acteristics similar to those of previously characterized mam-
malian RFs. DNA sequencing of this eukaryotic RF cDNA
revealed a remarkable sequence similarity to bacterial and
mitochondrial tryptophanyl-tRNA synthetases, with the great-
est similarity confined to the synthetase active site, and no
obvious similarity to bacterial RFs.
The genetic code is the means by which information is
translated fromDNA into protein. Two levels ofcoding occur
in all organisms; the classic triplet codons that specify the
linear arrangement of amino acids in a protein (1) and a
recently described "second genetic code" that imparts ami-
noacylation specificity to the tRNAs (2). While the transla-
tion of sense codons involves specific tRNA recognition via
RNA-RNA interactions, the termination ofpolypeptide trans-
lation involves the decoding of in-frame nonsense codons
(UAA, UAG, and UGA) by stop-codon-specific proteins (3).
Release factors (RFs) have been purified from both pro-
karyotes and eukaryotes. A single RF (eRF) that recognizes
all three nonsense codons has been described in eukaryotes
(4, 5). The best characterized eRF is the rabbit RF, which has
a subunit molecular weight of 54,000-56,000 and a ribosome-
dependent GTPase activity (4-7). In Escherichia coli, two
RFs (RF1 and RF2) mediate peptide chain termination (8-
10). RF1 is required for UAG- and UAA-directed termina-
tion, while RF2 is required for UGA- and UAA-directed
termination. Three separate activities can be independently
assessed for both prokaryotic and eukaryotic RFs: ribosomal
binding, stop-codon recognition, and peptidyl-tRNA hydrol-
ysis (3). While the primary structures of the E. coli RFs have
been elucidated (11), little is known of how codon specificity
is maintained.
To address this question of stop-codon recognition we have
used RF-specific monoclonal antibodies to isolate a cDNA
encoding the rabbit RF.§ We demonstrate that the protein
encoded by this cDNA has functional characteristics of a
mammalian RF. We also show that the rabbit RF protein has
sequence similarity to the prokaryotic and mitochondrial
tryptophanyl-tRNA synthetases, suggesting that a conserved
structural domain is required for both synthetase and RF
function and/or that the tryptophanyl-tRNA synthetases and
RF are derived from a common evolutionary lineage. Despite
the obvious functional similarities, there appears to be no
evolutionary or structural conservation between the bacterial
and eukaryotic RFs.
MATERIALS AND METHODS
Preparation of eRF Monoclonal Antibodies. Purified rabbit
RF was used to immunize BALB/c mice. Hybridomas were
prepared by standard techniques (12). Three lines of mono-
clonal antibodies were generated by these protocols.
Expression of eRF in E. colU and Monkey COS Cells. The
eRF clones were rescued from AZAP (Stratagene) by the
automated excision procedure (13). Expression of eRF in E.
coli was achieved by induction with 10 mM isopropyl f3-
D-thiogalactopyranoside (IPTG) for 2 hr prior to Western
immunoblot analysis.
The eRF A and B cDNAs were subcloned into p91023b (14)
by ligation into the EcoRI cloning site, selection on tetracy-
cline plates, and restriction mapping. The plasmids were
transfected into COS cells as described (15). Cells were
harvested after 72 hr by trypsin treatment and analyzed by
Western blotting.
Release Assay and eRF Activity. The f[3H]Met-tRNA/
AUG/80S ribosome substrate intermediates were prepared
as described (7). The peptide chain release assay was per-
formed as described (7), except that 10 mM Pipes (pH 7.0)
was substituted for 20 mM Tris and 10% (vol/vol) ethanol
was added.
For the eRF A activity assay, IPTG-induced cells were
ground in an equal amount ofalumina for 30 min and a soluble
extract was made by diluting the ground paste with ice-cold
RF buffer (10 mM Pipes, pH 7.0/100 mM KCI/1 mM 2-
mercaptoethanol/0.1 mM EDTA). The aqueous fraction was
separated from the debris by centrifugation at 10,000 x g for
15 min. A postribosomal fraction was obtained from the
supernatant by centrifugation at 100,000 x g for 4 hr. The
supernatant was then purified by a 0-65% ammonium sulfate
precipitation. The precipitate from the ammonium sulfate
step was dialyzed in RF buffer for 5 hr before 5 ml was loaded
onto a Sephadex G-75 gel permeation column (2 cm x 100 cm)
equilibrated with RF buffer. The eluted fractions were col-
lected in 2.5-ml aliquots. The expression and analysis of the
control pUO-p clone were carried out under identical con-
ditions.
Construction and Screening of a AZAP Expression Library.
A rabbit liver cDNA expression library was constructed in
AZAP (Stratagene) from 5 gg of rabbit liver poly(A)+ RNA
according to a published procedure (16). Antibody screening
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of the rabbit liver cDNA expression was carried out as
described (17).
Sequencing of eRF cDNA. The nucleotide sequence of the
rabbit eRF B cDNA was determined by subcloning the cDNA
into the vectors pTZ18 and pTZ19 (Pharmacia). Sequential
deletions were prepared by the exonuclease III method (18).
The single-stranded DNA was sequenced by the dideoxy
chain-termination method (19) with the manual Klenow poly-
merase procedure (Boehringer Mannheim) as well as an
automated fluorescence procedure (Applied Biosystems), as
described (20).
RESULTS
Isolation of the Rabbit RF cDNA. A total of500,000 primary
recombinants were screened with the three antibodies in
combination, and positive clones identified by using 1251_
labeled anti-mouse immunoglobulin as second antibody (17).
Three clones specific to the antibodies were identified. The
clones were designated eRF A, B, and C, following the
current convention for eukaryotic translation factors.
Restriction enzyme mapping of the three cDNA clones
revealed that the inserts are 2.5 kilobases (kb) long and have
identical restriction maps (data not shown). Northern anal-
ysis using the eRF A cDNA insert as a 32P-labeled probe
detected a single transcript of -2.5 kb (Fig. lA), indicating
that the eRF cDNA represents virtually the entire eRF
mRNA. Expression of the putative eRF cDNAs in E. coli
demonstrated that the polypeptide produced by eRF A is
larger than that of eRF B (Fig. 1B, lanes b and e), suggesting
that in E. coli eRF A is expressed as a fusion protein with the
amino-terminal end of f-galactosidase. In addition, eRF A
was expressed in bacteria at a higher level than clones B and
C. The basal level of eRF, as estimated by autoradiograph
densitometry, was at least 30-fold greater for eRF A than for
eRF B or C. The addition of IPTG, an inducer of 8-
galactosidase gene expression, effected a 5-fold increase in
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FIG. 1. The eRF mRNA transcript and cDNA expression in
bacteria and COS cells. (A) Northern analysis of 10 jig of rabbit liver
poly(A)+ RNA probed with 32P-labeled rabbit eRF cDNA. (B)
Western analysis ofeRF expression in E. coli and COS cells. Lanes:
a, partially purified RF from rabbit reticulocytes; b and c, extract (5
Al) of E. coli carrying eRF A and grown in the presence (+) or
absence (-) of 10mM IPTG, respectively; d, extract (25 p1) prepared
from eRF A-transfected COS cells; e and f, extract (25 p.1) of E. coli
carrying eRF B and grown in the presence (+) or absence (-) of 10
mM IPTG, respectively; g, extract (25 p.l) of eRF B-transfected COS
cells.
eRF protein expression in both eRF A and eRF B (Fig. 1B,
lanes b and c and lanes e and f). The proteins expressed by
eRF B and eRF C were identical in size (data not shown) and
migrated at the size consistent with translation initiation from
the authentic eRF AUG codon. When the cDNAs from eRF
A and eRF B were transfected into monkey COS cells under
the transcriptional control of the adenovirus major late pro-
moter, the polypeptides expressed were ofidentical size (Fig.
1B, lanes d and g) and were the same size as the authentic eRF
from rabbit reticulocytes (Fig. 1B, lane a). This suggests that
the increase in eRF protein in bacteria harboring eRF A is a
result of more efficient translation initiation from the 13-
galactosidase initiation AUG as compared to the authentic
eRF AUG used by eRF B.
Expression of eRF Activity in E. coli. To demonstrate that
the eRF clones encode a mammalian peptide chain termina-
tion factor, we carried out functional studies of the protein
encoded by eRF A. We chose to study eRF A, rather than
eRF B or eRF expressed in tissue culture cells, because ofthe
high level of eRF A expression in bacteria. eRFs do not
function with bacterial 70S ribosomes under any conditions,
and likewise, bacterial RFs do not function with 80S ribo-
somes (4, 21).
A whole cell extract was prepared from bacteria harboring
eRF A after induction with IPTG, and the extract was
fractionated on a Sephadex G-75 gel permeation column. The
peptide chain release assay was performed on these fractions
using rabbit reticulocyte ribosomes. Nonsense codon
(UAAA)-dependent peptide chain release activity was de-
tected from protein fractions of eRF A (Fig. 2A). Western
analysis showed that this activity coincided with an increas-
ing amount of eRF protein, indicating that the codon-
dependent peptide chain release activity was directly related
to the presence of eRF (Fig. 2A Inset).
No codon-dependent peptide chain release activity was
observed from a control extract prepared from bacteria
harboring the plasmid pUO-p (Fig. 2B), a pBluescript SK(-)
vector (Stratagene) containing the porcine urate oxidase
cDNA (22). These functional studies show that the eRF
cDNAs encode a mammalian RF.
In Vitro Assay Requirements for eRF Activity. Various
parameters affecting the in vitro termination assay that are
characteristic of a mammalian RF were analyzed. In contrast
to the bacterial and rat mitochondrial RFs, mammalian RF
activity functions only on eukaryotic 80S ribosome, is stim-
ulated by GTP, and requires nonsense codons to be in the
form of tetranucleotides rather than triplets (4, 7, 21). In
addition, the termination reaction catalyzed by rabbit RF on
rabbit ribosomes is stimulated by the presence of 10%
(vol/vol) ethanol. For heterologous reactions involving ribo-
somes and RFs from different species, the addition of ethanol
is essential for RF-directed codon-dependent hydrolysis of
the ribosome-bound model peptidyl-tRNA (fMet-tRNA) (21).
The addition of ethanol was required for codon-dependent
peptidyl-tRNA hydrolysis by eRF A. The in vitro termination
activity of eRF A with rabbit reticulocyte ribosomes was
dependent upon the presence of 10o ethanol and was stim-
ulated 3-fold by the addition of both GTP and stop codon
(Table 1). The removal of either GTP or stop codon from the
reaction decreased peptide chain termination activity by at
least 50o. By comparison, rat liver RF showed some termi-
nation activity in the absence of ethanol, but, in the presence
of stop codon and GTP, rat RF activity was stimulated 3-fold
by the addition of ethanol. A small amount of GTP- and
stop-codon-independent activity was observed for the rat RF
in the presence of ethanol. The absolute requirement for
ethanol by the eRF A extract may reflect the fact that eRF A
produces a fusion protein, and this fusion protein may not
bind 80S ribosomes efficiently. Although the mechanism of
ethanol-stimulated RF activity is unknown, the addition of
Biochemistry: Lee et al.
3510 Biochemistry: Lee et al.
(A) eRF cDNA
1 2 3 4 5 6 7 8 9 1C
3 0
2.0
a)
2o
-0)''
Orr
230
4 0,
0
Proc. NatI. Acad. Sci. USA 87 (1990)
sistent with previous studies demonstrating that RF-
dependent hydrolysis of ribosome-bound model peptidyl-
tRNA can occur in the absence of stop codons or GTP if the
in vitro assay reaction contains a sufficient level of ethanol
(23, 24). The eRF A fraction showed peptide chain termina-
tion activity with the tetramers but not the triplet nonsense
codons (data not shown). These results demonstrate that the
expressed eRF is similar in character to the mammalian RF.
Primary Structure of the Rabbit RF. The complete nucle-
otide sequence ofthe rabbit eRF B cDNA was determined for
2.4 both strands by manual and automated DNA sequencing (18,
19). The DNA sequence and its predicted protein sequence
are shown in Fig. 3. The rabbit eRF cDNA contains a
143-base-pair (bp) 5' untranslated region followed by a single
6 ATG codon that begins an uninterrupted open reading frame
of 1425 bp, corresponding to a protein length of 475 amino
acids. The TAA stop codon at position 1571 is followed by
- 876 bp of 3' untranslated sequence, including the conven-
0 8 tional polyadenylylation signal AATAAA at position 2427.
E The deduced polypeptide of 475 amino acids has a calculated
molecular weight of 53,964, a value consistent with the
co subunit molecular weight of 54,000-56,000 predicted by
0 N SDS/polyacrylamide gel electrophoresis (5, 7).
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FIG. 2. Functional expression of eRF in bacteria. Whole cell
extracts prepared from bacteria harboring eRF A (A) or the control
plasmid pUO-p (B) were fractionated on a Sephadex G-75 gel
permeation column, and the fractions were assayed for protein
content (---) and peptide chain release activity (e). Inset in A shows
a Western analysis of the corresponding fractions with the anti-RF
antibodies.
ethanol has been shown to enhance the formation of a
RF/ribosome/codon complex in both eukaryotic and pro-
karyotic RF binding assays, and this may have contributed to
the enhanced hydrolysis of the model peptidyl-tRNA in the
above experiments and in prior studies using heterologous
ribosomes and RFs (8, 21, 23). These results are also con-
Table 1. Substrate requirements of eRF
fl3H]Met released,
Substrate mixture eRF A Rat I
Complete 3054 3
Minus GTP 1460
Minus UAAA 1389
Minus GTP and UAAA 885
Minus ethanol 0 1
cpm
liver RF
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AATTCGGGTAAAGACGCCGCGGGCCGGGCAGCGCGTCCTCGGCTCTGCAGCGGCCCCTCG
GCGCGTCCGCCAGACCCGGGCTTGCCTTGACCCTGGACAGCTCCTCCTCCTCCCTAGCCA
GCTGTGAGCGTCAGTGCTGGAAGATGGCGGACGTGACCAACGGCGAGCGGTGTGCCTCTC
M A D V T N G E R C A S
CACAGGAGCTGTTCAGCAGCATCGCGGCGCAGGGCGAGCTCGTGAAGTCCCTCAAAGCTA
P Q E L F S S I A A Q G E L V K S L E A
GAAAGGCCCCGAAGGAGGAAATTGATTCTGCAGTAAAGATGTTGCTGTCGTTAAAAACGA
R K A P K E E I D S A V K M L L S L K T
GCTACAAGGAGGCCATGGGGGAGGACTACAAGGCTGACTGCCCTCCAGGGAACTCGACCC
S Y K E A M G E D Y K A D C P P G N S T
CCGACAGCCACGGTGACCCAGAAGCCGTAGATGACAAAGAGGATTTTGTGGACCCGTGGA
P D S H G D P E A V D D K E D F V D P W
CAGTACGGACGAGCAGTGCGAAAGGCATTGACTACGACAAGCTCATCGTTCAGTTCGGAA
T V R T S S A K G I D Y D K L I V Q F G
GCAGTAAAATCGACAAGGAGCTGGTGAACCGGATCGAGAGAGCCACCGGCCAGAGACCGC
S S K I D K E L V N R I E R A T G Q R P
ACCGCTTCCTGCGCAGGGGCATCTTCTTCTCACACAGAGATATGAACCAAGTTCTTGATG
H R F L R R G I F F S H R D M N Q V L D
CCTACGAGAACAAGAAGCCGTTTTACCTGTACACGGGCAGGGGCCCTCTTCTGAAGCAAT
A Y E N K K P F Y L Y T G R G P L L K Q
GCAATGTAGGTCACCTCATCCCGTTTATTTTCACAAAGTGGCTGCAGGATGTGTTTGACG
C N V G H L I P F I F T K W L Q D V F D
TGCCGCTGGTGGTGCAGATGTCGGATGACGAGAAGTACCTGTGGAAGGACCTCACGCTGG
V P L V V Q M S D D E K Y L W K D L T L
AGCAGGTCTATGGCTACACCCTGGAGAACGCCAAGGACATCATGCCCTGTGGCTTCGATG
E Q V Y G Y T L E N A K D I M P C G F D
TCAACAAGACGTTCATCTTCTCTGACCTTGACTACATGGGGATGAGCCCAGGCTTCTACA
V N K T F I F S D L D Y M G M S P G F Y
AGAATGTGGTGAAGATTCAGAAGCACGTCACCTTCAACCAAGTGAAAGGCATCTTCGGCT
K N V V K I Q K H V T F N Q V K G I F G
TCACCGACAGTGACTGCATCGGGAAGATCAGTTTTCCTGCCATCCAGGCTGCGCCTTCCT
F T D S D C I G K I S F P A I Q A A P S
TCAGCAACTCCTTCCCCCAGATCTTCCATGGCCAGGCAGACATCCAGTGCCTCATCCCCT
F S N S F P Q I F H G Q A D I Q C L I P
GTGCCATTGACCAGGACCCCTACTTCAGGATGACCAGGGACGTCGCGCCCAGGATCGGCT
C A I D Q D P Y F R M T R D V A P R I G
ATCCTAAACCGGCCCTGCTGCACTCGACCTTCTTCCCTGCTCTGCAGGACGCCCAGACCA
Y P K P A LL H S T F F P A L Q D A Q T
AGATGAGTGCCAGTGACCCCAACTCCTCCATCTTCCTCACCGACACGGCCAAGCAGATCA
K M S A S D P N S S I F L T D T A K Q I
AGACCAAGGTCAACAAGCACGCATTTTCTGGGGGCAGAGACACCATCGAGGAGCACCGGC
K T K V N K H A F S G G R D T I E E H R
AGTTTGGGGGCAACTGTGACGTGGACGTCTCCTTCATGTACCTGACCTTCTTCCTGGAGG
Q F G G N C D V D V S F M Y L T F F L E
ACGACGACAAGCTGGAGCAGATCAGAAAGGATTACAGCAGCGGCGCCATGCTCACCGGCG
D D D K L E Q I R K D Y S S G A M L T G
AGCTGAAGAAGGAGCTGATAGACGTCCTGCAGCCGCTGGTCGCCGAGCACCAGGCCCGGC
E L K K E L I D V L Q P L V A E H Q A R
GCAAGGAGGTCACGGACGAGATGGTGAAGGAGTTCATGACGCCCCGGCAGCTGTGCTTCC
R K E V T D E M V K E F M T P R Q L C F
ACTATCAGTAACACGGGGTGGGAGTTACCCATAACCCAGCCCAGTGGGGTCGCCGCAGCC
H Y Q STOP
CGTGGGCTCTGTCGCACGGTACTGCTGGGCCTGGTGTCGTGAGCCCTGTGTGTACCGACC
CTGTTTCTTCATCGTCTGTCTTGGCCAGAACACTGCGGGTGATTGGGTGCTGGCTAAGGT
GGCGTGGTCGCATAGCAGCGCCTGCTGTGAGTCTCACCCACAAAGCAGCCAGGGTGCCGC
GCCTCTGCCTCGGAGGGCTGCCCTGGAAAACAGCCCAGGGTTCCAAATGTACCCTTAGAA
TCTGCTCTTAAAATCTGCACTCTGTGGACACATACATGGAGCCAGAGTGTCGCCTTGTGA
AACCTAAGGCTTGACAGGCTGACCTGGGCAGTTTAATGGGCACCTAGTACACTCCAGCCC
TCGCCAGGAAAGAAGCAGTGAGTGGCCCAAAGCTTTGCCCGACGTGGAAGTGACACAGCA
CCACTTTCGAGCTGTTTGCACGGGGCTGTGGGCAGAGGTGGGCAGGCTCACTGAGCTGGG
TCCTGTGGGTGAGACTTGCGGACTGCGCTTCCTAACCCAGACCATGCATGTATCCCCGTT
CTCTTCCCCGACTACCAATGTGGGCTCCACCGAGCCATCCCAGTGGTGTCCGGTGGCCTG
GCCGCGCTGCCTTTGCAGGGCTTCTCTCTGTCACCCGACCGCAGTGGGCACACAGAGCAG
TGCACTGGCCAAGCGGTGGACGCCGCCTGGGGGACCCTCCGCGGTTTCTCCGTGTACCGT
GTGTGGTCCTGGGAAAACAGAAGCCACATCTCAGGGAAAGGCTCTGGCTGGAGTCCGCCC
TGCCCCTTGTCACTCGCTTGGGTATA,5ATACTTTGCTCCCACCCCC
FIG. 3. The complete nucleotide and predicted amino acid se-
quence of the rabbit eRF cDNA. The predicted initiator methionine
codon begins at nucleotide position 144; the numbers on the left
indicate the nucleotide and amino acid positions. The polyadenyl-
ylation signal AATAAA is underlined and the poly(A) sequence has
been omitted.
The substrates for eRF termination activity were at the following
final concentrations: 0.2 mM GTP; 2 A260 units ofUAAA per ml; and
10% (vol/vol) ethanol. Background activity in the absence of stop
codon (UAAA), GTP, and ethanol has been subtracted from each.
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A comparison of the predicted eRF protein sequence to the
E. coli RF1 and RF2 protein sequences failed to demonstrate
any significant amino acid similarity. This is not surprising
since mammalian and bacterial RFs, although demonstrating
functional similarities when each is tested on its own ribo-
somes, do not crossreact functionally when tested on the
other's ribosomes (4, 21). A computer-aided search of se-
quences in the National Biomedical Research Foundation
protein data bank (Release 59) identified a short region of
significant sequence similarity to tryptophanyl-tRNA syn-
thetase peptide sequences from yeast mitochondria, E. coli,
and Bacillus stearothermophilus (25-27). Fig. 4 shows one
possible alignment of these proteins; there is sequence sim-
ilarity throughout the entire eRF protein and especially
between amino acid positions 280 and 375, where 20o of the
amino acids are identical in all four proteins. In one particular
region between amino acids 352 and 375, almost 70%6 of the
eRF residues are identical with those of one or more of the
tryptophanyl-tRNA synthetases. There is also a short region
of sequence similarity between the carboxyl terminus ofeRF
and that of yeast cytosolic methionyl-tRNA synthetase (data
not shown).
The eRF region exhibiting the highest degree of similarity
to the tryptophanyl-tRNA synthetases (eRF amino acids
353-360) is also the most highly conserved region among the
different tRNA synthetases (28). Table 2 compares this
region with the corresponding region of a number of tRNA
synthetases. Based upon biochemical and crystallographic
data (28, 32, 33), this region is thought to contribute to the
active site of the synthetases. Crosslinking studies of the
methionyl- and tyrosyl-tRNA synthetases place the lysine
residue of the consensus Met-Ser-Lys sequence in close
proximity to the 3' acceptor stem of their respective tRNAs
(32, 33). The recently determined crystal structure of the
glutamyl-tRNA synthetase bound to its cognate tRNA and
ATP demonstrates an interaction between the same lysine
and ATP, further implicating this region in the catalytic
function of the synthetase (34). Since RFs do not have an
FIG. 4. Sequence comparison of
the predicted rabbit eRF protein
and the bacterial and yeast mito-
chondrial tryptophanyl-tRNA syn-
thetases. Top line, rabbit eRF (R.
eRF); the second, third, and
fourth lines, tryptophanyl-tRNA
synthetases from yeast mitochon-
dria (Y. mit), E. coli (E. col), and
B. stearothermophilus (B. ste).
The amino acid sequences were
aligned by the program GENALIGN
(36) and visual inspection. Gaps
are represented by dashes and
only those residues found to be
conserved with eRF are boxed.
associated ATPase activity and the lysine in this region of
eRF has been replaced with an alanine, it is unknown what
role these residues may play in eRF function; however, the
high degree of sequence conservation within this region
clearly suggests that it is important.
DISCUSSION
We have identified three cDNA clones encoding the rabbit
RF. The clones were isolated by screening a AZAP expres-
Table 2. Alignment of eRF residues with the highly conserved
putative active-site region of the tRNA synthetases
eRF/tRNA
synthetase Residues Sequence Ref.
* **** ****
eRF (rabbit) 350-360 AQTKMSASDPN
Met (E. coli) 329-339 NGAKMSKSRGT 28
Met (yeast cyt.) 522-532 ENGKFSKSRGV 28
lie (E. ccli) 599-609 QGRKMSKSIGN 28
Trp (E. ccli) 192-202 PTKKMSKSDPN 27
Trp (B. ste.) 189-199 PTKKMSKSDPN 25
Trp (yeast mit.) 241-251 PEKKMSKSDPN 26
Leu (yeast mit.) 657-667 SYEKMSKSKYN 29
Gly (E. coli) 86-96 AEGKPSKAPEG 30
Glu (E. colt) 234-244 DGKKLSKRHEA 31
Tyr (E. colt) 223-233 TVPLITKADGT 28
Tyr (B. ste.) 219-229 TIPLVTKADGT 28
Gln (E. coli) 264-274 EYTVMSKRKLN 28
Phe (E. colh) 60-70 DKLRVTKVNVG 28
Ala (E. coli) 813-823 LIAGVSKDVTD 28
The aligned tRNA synthetases are as follows: methionyl (Met),
isoleucyl (Ile), tryptophanyl (Trp), leucyl (Leu), glycyl (Gly), glu-
tamyl (Glu), tyrosyl (Tyr), glutaminyl (Gln), phenylalanyl (Phe), and
ananyl (Ala). The yeast mitochondrial (mit.) and cytoplasmic (cyt.)
sequences are from Saccharomyces cerevisiae. B. ste., B. stearo-
thermophilus. Asterisks indicate positions of identical or chemically
similar amino acids in at least three synthetases and eRF.
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sion library with RF-specific monoclonal antibodies. Func-
tional studies of the protein encoded by this cDNA demon-
strated that it has in vitro activities characteristic of a
mammalian RF. Comparison ofthe predicted eRF amino acid
sequence failed to demonstrate any homology to the E. coli
RF1 or RF2 proteins but did reveal amino acid sequence
similarities to several regions of the tryptophanyl-tRNA
synthetases of yeast mitochondria, E. coli, and B. stearo-
thermophilus. It is of interest that the region of highest
homology between eRF and tryptophanyl-tRNA synthetases
is also highly conserved in a group of other tRNA syn-
thetases.
What could account for the similarity to the tryptophanyl-
tRNA synthetases? Several possibilities can be envisioned.
One is that the conserved amino acids provide eRF with a
structural conformation required for peptidyl-tRNA binding
during peptide chain termination. We speculate that in the
absence of an occupied aminoacyl (A) site, eRF binds the
peptidyl-tRNA occupying the peptidyl (P) site. Since the eRF
"active site" lacks the lysine required for ATP binding, it
does not form an ester bond but rather alters the peptidyl-
tRNA conformation, thereby allowing the peptidyltrans-
ferase center access to the peptidyl-tRNA ester linkage,
where water then acts as a nucleophile to hydrolyze the
peptidyl-tRNA ester bond.
Another possibility is that the primordial eRF used a tRNA
for decoding specificity and hence bound a tRNA similar to
tRNATII. One argument against the use of stop-codon-
specific tRNAs is that in Tetrahymena thermophila the two
independent sense tRNAs specific for UAA and UAG are
proposed to have arisen from the existing tRNAGIn by a gene
duplication event rather than by the independent evolution of
separate tRNAs (35). Alternatively, since a mechanism was
required for decoding stop codons, a primitive RF may have
"borrowed" features from the primitive UGA-decoder tryp-
tophanyl-tRNA synthetase, leading to the present-day se-
quence similarities with the evolutionarily more primitive
tryptophanyl-tRNA synthetases.
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